Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drugs compared

Compare all 4 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drugs side by side, used for conditions such as hepatitis b, chronic, acquired immunodeficiency syndrome. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is baraclude.

Top-rated hepatitis b virus nucleoside analog reverse transcriptase inhibitor: 1. Baraclude · 2. Viread · 3. Lamivudine

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drugs compared side by side, with pharmaranks' FDA recall-safety rating
DrugGenericSafety ratingFDA recall-based
BaracludeEntecavir72/100
VireadTenofovir Disoproxil Fumarate70/100
Lamivudine—66/100
EpivirLamivudineNot yet rated

The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.

Best hepatitis b virus nucleoside analog reverse transcriptase inhibitor by condition

for chronic hepatitis bfor acquired immunodeficiency syndrome

Full ranking · 4 drugs

  1. 1

    baraclude

    Entecavir

    72/100
  2. 2

    viread

    Tenofovir Disoproxil Fumarate

    70/100
  3. 3

    lamivudine

    Lamivudine

    66/100
  4. 4

    epivir

    Lamivudine

    New

Frequently asked questions

What is the Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drug class?

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 4 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor products, each independently rated.

Are all Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drugs the same?

No. Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

What conditions do Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drugs treat?

Per NIH RxClass drug-classification data, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drugs are used for conditions including hepatitis b, chronic, acquired immunodeficiency syndrome.

Which Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drug is best-rated?

By our independent rating, baraclude currently ranks highest among Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.

Sources: the Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.